Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » NHGRI to Award $14.3M in Funding for Mendelian Genomics Centers

NHGRI to Award $14.3M in Funding for Mendelian Genomics Centers

Feb 04, 2020
|
staff reporter

NEW YORK — The National Human Genome Research Institute (NHGRI) said last month that it has earmarked roughly $14.3 million over the next five years to fund research under its Centers for Mendelian Genomics initiative.

The agency is also seeking applications for projects focused on the development and distribution of cost-effective genomic resources for the broader research community in partnership with the National Cancer Institute (NCI).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Millions of Tests

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Court Pick and Science

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Arthur Ashkin Dies

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

PNAS Papers on Alzheimer's Transcriptomes, Bladder Cancer Mutations, CRC Drivers

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.

Oct
06
Featured Webinar

Understanding Human Pulmonary Fibrosis using Single-Cell Technologies

Sponsored by
10x Genomics

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure. 

Oct
08
Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct
13
Featured Webinar

Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation

Sponsored by
Lexogen

This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.

Oct
14
Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

What's Popular?

In Sequencing

  1. Sema4, Janssen Partner on Patient Identification for Cancer Clinical Trials

  2. Alzheimer's Disease Linked to Epigenetic Changes in Multi-Omic Study

  3. Swift Biosciences, BillionToOne Partner to Commercialize COVID-19 Test

  4. UK Government Unveils New Genomic Healthcare Strategy

  5. NIH Awards Two SBIR Grants Totaling $3.9M to Phase Genomics

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.